TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30083236

Group type: EXPERIMENTAL
Intervention: D-Flex measurement device
Number of subjects: 20

Group type: COMPARATOR
Intervention: Goniometer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Inclinometer
Number of subjects: 20
Study: 26429650

Group type: EXPERIMENTAL
Intervention: Definitive radiotherapy (DRT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 73
Study: 25478537

Group type: EXPERIMENTAL
Intervention: GlideScope video-laryngoscope (GVL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Macintosh direct laryngoscope (MDL)
Number of subjects: 60
Study: 22731754

Group type: EXPERIMENTAL
Intervention: 500/100 μg fluticasone/salmeterol Diskus daily
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: 400/24 μg extrafine beclomethasone/formoterol pMDI daily
Number of subjects: 422

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 422
Study: 20092966

Group type: EXPERIMENTAL
Intervention: modafinil (400mg once daily)
Number of subjects: 71

Group type: COMPARATOR
Intervention: placebo (once daily)
Number of subjects: 71
Study: 18682624

Group type: EXPERIMENTAL
Intervention: Phentolamine mesylate (PM) injection
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control (sham injection)
Number of subjects: 152
Study: 16425390

Group type: EXPERIMENTAL
Intervention: Cefotaxime (1 g every 6 h for 5 days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Amikacin (500 mg once daily for 5 days)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 37

Group type: COMPARATOR
Intervention: Amikacin
Number of subjects: 37
Study: 14674839

Group type: EXPERIMENTAL
Intervention: Trace conditional discrimination learning (light conditional stimulus S+/S‐ and tone conditioned stimulus CS with 1‐s trace)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Delay conditional discrimination learning (temporal separation eliminated)
Number of subjects: 16
Study: 10389550

Group type: EXPERIMENTAL
Intervention: Beclomethasone 168 micrograms plus salmeterol 42 micrograms twice daily
Number of subjects: 514

Group type: COMPARATOR
Intervention: Beclomethasone 336 micrograms twice daily
Number of subjects: 514
Study: 8896506

Group type: EXPERIMENTAL
Intervention: Salmonella abortus equi endotoxin (0.8 ng/kg) given intravenously at 1900 h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salmonella abortus equi endotoxin (0.8 ng/kg) given intravenously at 0900 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 1354949

Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324) 2 mg to 75 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324) 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324) up to 75 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324)
Number of subjects: 10
Study: 6373217

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (Dusodril) 600 mg orally
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 31455105

Group type: EXPERIMENTAL
Intervention: Confederate trustee with tears (neutral or sad facial expression)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confederate recipient with tears (neutral or sad facial expression)
Number of subjects: 0
Study: 30100298

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diadynamic current
Number of subjects: 30
Study: 27555206

Group type: EXPERIMENTAL
Intervention: ACB with local anesthetic and buprenorphine
Number of subjects: 100

Group type: COMPARATOR
Intervention: ACB with local anesthetic alone
Number of subjects: 100
Study: 24856464

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 μg)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 μg)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 μg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no cervical priming agent)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: All groups (oral, sublingual, vaginal)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 160
Study: 21855274

Group type: EXPERIMENTAL
Intervention: High-flexion mobile-bearing knee
Number of subjects: 388

Group type: COMPARATOR
Intervention: Fixed-bearing control
Number of subjects: 388
Study: 20832986

Group type: EXPERIMENTAL
Intervention: Buspirone (a serotonin-selective agonist) administered in a double-blind, randomized, placebo-controlled protocol.
Number of subjects: 42
Study: 17884510

Group type: EXPERIMENTAL
Intervention: Computer assisted alignment system (MICA group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional alignment guide (MIS group)
Number of subjects: 74
Study: 16301343

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14703
Study: 12134097

Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 167
Study: 11039606

Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate (MPSL: 10 mg/kg body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MPSL followed by continuous infusion of urinary trypsin inhibitor (UTI) for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bolus administration of MPSL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Administration of UTI in early postoperative phase after MPSL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative MPSL followed by UTI infusion for only one hour
Number of subjects: 0
Study: 7598441

Group type: EXPERIMENTAL
Intervention: Salbutamol (n = 20)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (n = 23)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combined Salbutamol and Ipratropium bromide (n = 24)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Normal saline (n = 22)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Children aged more than 3 months
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Children positive for RSV infection
Number of subjects: 89
Study: 2218733

Group type: EXPERIMENTAL
Intervention: Dinoprostone (Prepidil Gel) applied 6 hours before abortion
Number of subjects: 73

Group type: COMPARATOR
Intervention: Dinoprostone (Prepidil Gel) applied 4 hours before abortion
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Dinoprostone (Prepidil Gel)
Number of subjects: 73
Study: 340949

Group type: EXPERIMENTAL
Intervention: Single 3-g oral dose of amoxicillin
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional therapy (10 days of amoxicillin, 250 mg, four times per day)
Number of subjects: 61
Study: 31802534

Group type: EXPERIMENTAL
Intervention: Propofol TCI with BIS monitoring (BIS scores of 60-80)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Propofol TCI without BIS monitoring (BIS-blind group, monitoring scores of 1-2)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 200
Study: 31014435

Group type: EXPERIMENTAL
Intervention: Flu+Mon+Ket
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Ket
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Flu or Mon alone
Number of subjects: 280

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 280
Study: 28864219

Group type: EXPERIMENTAL
Intervention: Regenerative endodontic treatment (RET)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Apexification
Number of subjects: 118
Study: 25843397

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastrojejunostomy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LRYGB with a small stomach pouch
Number of subjects: 60
Study: 23503480

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg/day) for 12 months
Number of subjects: 31
Study: 21199980

Group type: EXPERIMENTAL
Intervention: Adolescents (≤19 years)
Number of subjects: 831

Group type: COMPARATOR
Intervention: Adults (>19 years)
Number of subjects: 831
Study: 18553060

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with removable suture (group B)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard trabeculectomy (group A)
Number of subjects: 66
Study: 16896166

Group type: EXPERIMENTAL
Intervention: Whey protein ingestion before exercise (PRE)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Whey protein ingestion after exercise (POST)
Number of subjects: 17
Study: 15099174

Group type: EXPERIMENTAL
Intervention: Implementation intentions intervention
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 264
Study: 17014579

Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy (removal of 300-500 mL of blood every 14 days until serum ferritin < 100 microg/L)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (follow-up without phlebotomy therapy)
Number of subjects: 48
Study: 10513131

Group type: EXPERIMENTAL
Intervention: Virtual reality-based simulator training for DRE
Number of subjects: 2

Group type: COMPARATOR
Intervention: Modified Merck Procar simulator training for DRE
Number of subjects: 2
Study: 8739008

Group type: EXPERIMENTAL
Intervention: Psychiatric consultation
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Full implementation of the protocol
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Post hoc-defined patient categories (cases with hernia, chronic and nonchronic cases)
Number of subjects: 104
Study: 2008865

Group type: EXPERIMENTAL
Intervention: Naltrexone (100-150 mg/d)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 6807439

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone 600 mg/m2 daily for three days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral prednisolone 3 mg/kg daily for three days
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral prednisolone
Number of subjects: 22
Study: 31974279

Group type: EXPERIMENTAL
Intervention: Vertebroplasty (VP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 30608050

Group type: EXPERIMENTAL
Intervention: Vaccine-plus-behavior-change (handwashing promotion and drinking water chlorination)
Number of subjects: 60000

Group type: EXPERIMENTAL
Intervention: Cholera-vaccine-only
Number of subjects: 60000

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60000

Group type: EXPERIMENTAL
Intervention: Presence of soap and water in handwashing station
Number of subjects: 60000
Study: 29438123

Group type: EXPERIMENTAL
Intervention: Dry eye group (n=46)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Non-dry eye group (n=66)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dry eye group subjects
Number of subjects: 112

Group type: COMPARATOR
Intervention: Non-dry eye group subjects
Number of subjects: 112
Study: 26886418

Group type: EXPERIMENTAL
Intervention: Pioglitazone (target dose, 45 mg daily)
Number of subjects: 3876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3876

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 3876
Study: 25223743

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (SNS) ON
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (SNS OFF)
Number of subjects: 20
Study: 22148897

Group type: EXPERIMENTAL
Intervention: Strontium ranelate 1 g/day
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Strontium ranelate 2 g/day
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (1 or 2 g/day)
Number of subjects: 1600
Study: 20806323

Group type: EXPERIMENTAL
Intervention: Developing motor control; participants reported target presence or absence by pressing a key or marking on recording sheets.
Number of subjects: 0
Study: 17947609

Group type: EXPERIMENTAL
Intervention: AA/DHA supplementation (10 gel caps containing 500 mg of AA and 1000 mg of DHA daily for 6 weeks)
Number of subjects: 9

Group type: COMPARATOR
Intervention: OA/LA supplementation (250 mg of linolenic acid and 125 mg of oleic acid daily for 6 weeks)
Number of subjects: 9
Study: 15617993

Group type: EXPERIMENTAL
Intervention: Cisplatin (CP) + Vinorelbine (VNR) 25 mg/m(2) on days 1 and 8 as an intravenous bolus plus CP 75 mg/m(2) on day 1 (regimen A)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Cisplatin (CP) + Gemcitabine (GEM) 1200 mg/m(2) on days 1 and 8 as an intravenous 30-min infusion plus CP 75 mg/m(2) on day 1 (regimen B)
Number of subjects: 272
Study: 12384827

Group type: EXPERIMENTAL
Intervention: Pramlintide (100 microg/h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10414012

Group type: EXPERIMENTAL
Intervention: Parents as Teachers (PAT) program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parents as Teachers (PAT) program with comprehensive case management services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parents as Teachers (PAT) program with more intensive services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home visits (part of the PAT program)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for primarily Spanish-speaking Latino families
Number of subjects: 0
Study: 7798688

Group type: EXPERIMENTAL
Intervention: PRP polysaccharide vaccine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hib conjugate PRP-D vaccine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hib conjugate HbOC vaccine
Number of subjects: 50

Group type: COMPARATOR
Intervention: No vaccine (unimmunized)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Conjugate vaccines
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PRP IgG1 subclass
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Immunized mothers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PRP conjugate vaccines
Number of subjects: 50
Study: 2186591

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 36
Study: 29383649

Group type: EXPERIMENTAL
Intervention: Revised Children's Anxiety and Depression Scale (RCADS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Network analysis of RCADS anxiety items
Number of subjects: 126
Study: 30396622

Group type: EXPERIMENTAL
Intervention: Yoga as an adjunct therapy
Number of subjects: 0
Study: 27550184

Group type: EXPERIMENTAL
Intervention: Gongjin-dan (GJD) administered twice daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo administered twice daily
Number of subjects: 24
Study: 24508316

Group type: EXPERIMENTAL
Intervention: Manual mobilization of the wrist (10 minutes, integrated into therapy twice a week for 6 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (therapy based on Dutch guidelines for stroke without manual mobilization)
Number of subjects: 18
Study: 22975763

Group type: EXPERIMENTAL
Intervention: peginterferon + ribavirin + boceprevir (PRB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: peginterferon + ribavirin (PR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study: 20429912

Group type: EXPERIMENTAL
Intervention: Duodenum-preserving pancreatic head resection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pancreatoduodenectomy
Number of subjects: 100
Study: 17170051

Group type: EXPERIMENTAL
Intervention: 5 mg BIIL 284
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: 25 mg BIIL 284
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: 75 mg BIIL 284
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 16314680

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no OMT)
Number of subjects: 29
Study: 12452546

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 20
Study: 9794948

Group type: EXPERIMENTAL
Intervention: Early surfactant treatment (100 mg/kg body weight bovine surfactant)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Late surfactant treatment (100 mg/kg body weight bovine surfactant)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Early surfactant treatment
Number of subjects: 317

Group type: COMPARATOR
Intervention: Late surfactant treatment
Number of subjects: 317
Study: 7708981

Group type: EXPERIMENTAL
Intervention: Alfentanil (A)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Midazolam + Alfentanil (M+A)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Midazolam (M)
Number of subjects: 103
Study: 2615932

Group type: EXPERIMENTAL
Intervention: 2 g of L-tryptophan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 208034

Group type: EXPERIMENTAL
Intervention: Quinestrol 0.2 mg once weekly
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Quinestrol 0.1 mg once weekly
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens 1.25 mg daily for 21 days on and 7 days off
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 30601336

Group type: EXPERIMENTAL
Intervention: Combination therapy of tenofovir (TDF) and telbivudine (LdT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Tenofovir (TDF) single treatment
Number of subjects: 121
Study: 27364375

Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (1.3 mmol/L)
Number of subjects: 50

Group type: COMPARATOR
Intervention: High calcium dialysate (1.6 or 1.75 mmol/L)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (LC and HC)
Number of subjects: 50
Study: 26237308

Group type: EXPERIMENTAL
Intervention: Threshold Suspend (TS) feature
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control Group (sensor-augmented pump only)
Number of subjects: 247
Study: 24004882

Group type: EXPERIMENTAL
Intervention: Overground visual cue training (O-VCT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treadmill visual cue training (T-VCT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 60
Study: 21352609

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA/PQP)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 304
Study: 17689755

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy (four drops of essential oil diluted with 20 ml of hot water and inhaled for 30 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no aromatherapy)
Number of subjects: 30
Study: 15651074

Group type: EXPERIMENTAL
Intervention: Standard support group
Number of subjects: 181

Group type: COMPARATOR
Intervention: Complementary/alternative (CAM) oriented intervention
Number of subjects: 181
Study: 12497304

Group type: COMPARATOR
Intervention: Fluoxetin (37 patients, dosage: 20-40 mg/day)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Amitriptyline (40 patients, dosage: 25-75 mg/day)
Number of subjects: 77
Study: 9845814

Group type: EXPERIMENTAL
Intervention: Film-coated matrix pellets with enteric polymers (methacrylate copolymers, hydroxypropyl methylcellulose acetate succinates, cellulose acetate phthalate) as binders and coating material.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Uncoated pellets for furosemide.
Number of subjects: 0
Study: 7540898

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (200 micrograms)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (800 micrograms)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (400 micrograms)
Number of subjects: 14
Study: 1673953

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg daily (n = 54)
Number of subjects: 107

Group type: COMPARATOR
Intervention: H2 receptor antagonist (n = 53)
Number of subjects: 107
Study: 6269769

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus prophylactic whole brain radiation therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 30
Study: 28489629

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA; 0.057 mA·cm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 26105140

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 26376805

Group type: EXPERIMENTAL
Intervention: Paroxetine (20-40 mg)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Imipramine (200-300 mg)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 24247554

Group type: EXPERIMENTAL
Intervention: GM‐CSF (leukine), 500 μg/day 3 times a week for 4 weeks
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: GM‐CSF
Number of subjects: 159
Study: 21086125

Group type: EXPERIMENTAL
Intervention: Proctored training (automated simulator feedback plus human expert feedback)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Independent training (simulator feedback alone)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Observation of the actual procedure
Number of subjects: 32

Group type: COMPARATOR
Intervention: Watching the instructional video alone
Number of subjects: 32
Study: 18412964

Group type: EXPERIMENTAL
Intervention: Involvement of nurse specialists in primary care for urinary incontinence
Number of subjects: 350

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 350
Study: 17053841

Group type: EXPERIMENTAL
Intervention: Proposed clinical classification of tetanus patients (grades I to IV)
Number of subjects: 64
Study: 15181047

Group type: EXPERIMENTAL
Intervention: Low-Fat Diet (LF)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Both diets
Number of subjects: 31
Study: 11069440

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (once daily for 9 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous amlodipine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Grapefruit juice coadministration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 20